COSCIENS Biopharma Inc. GAAP EPS of -$3.45, revenue of $2.5M
Seeking Alphavia NewsData.io

COSCIENS Biopharma Inc. reports Q3 GAAP EPS of -$3.45 and revenue of $2.5 million, up 66.7% year over year.
Headline and summary provided via NewsData.io. The full article and its copyright belong to the original publisher.